SLGL Sol-Gel Technologies Ltd.
Healthcare$76.73+12.33%ClosedMarket Cap: $215.6M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
9.37
P/S
11.12
EV/EBITDA
18.87
DCF Value
$-61.05
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-39.2%
Net Margin
-31.6%
ROE
-24.3%
ROA
-20.5%
ROIC
-31.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $696.0K | 100.0% | $-3.5M | $-3.0M | $— | — |
| FY null | $19.4M | 99.4% | $-7.6M | $-6.1M | $— | — |
| Q3 null | $400.0K | 100.0% | $-6.3M | $-5.9M | $— | — |
| Q2 null | $17.3M | 100.0% | $11.2M | $11.6M | $— | — |
| Q1 null | $1.0M | 100.0% | $9.1M | $-8.8M | $— | — |
| Q4 null | $278.0K | 100.0% | $-6.1M | $-5.8M | $— | — |
| FY null | $11.5M | 98.0% | $-12.0M | $-10.6M | $— | — |
| Q3 null | $5.4M | 100.0% | $-828.0K | $-366.0K | $— | — |
| Q2 null | $5.4M | 55.1% | $1.6M | $2.0M | $— | — |
| Q1 null | $466.0K | -1047.0% | $-6.7M | $-6.3M | $— | — |
| Q4 2023 | $447.0K | -833.1% | $-5.4M | $-4.8M | $-0.17 | — |
| FY null | $1.6M | -1414.9% | $-29.3M | $-27.2M | $— | — |